S-1/A: Avant Technologies Eyes $20 Million Capital Injection Through Equity Financing Agreement with GHS Investments
S-1/A Filing
Avant Technologies enters into an equity financing agreement with GHS Investments, potentially securing up to $20 million over 24 months through the sale of common stock.
Summary
- Avant Technologies has entered into an equity financing agreement with GHS Investments, LLC, effective July 17, 2024.
- The agreement allows Avant Technologies to sell up to $20 million worth of its common stock to GHS Investments over a 24-month period.
- The purchase price for the shares will be 80% of the lowest traded price during the ten consecutive trading days preceding the Put Notice Date.
- Following an up-list to the NASDAQ or a national exchange, the Purchase Price shall be ninety percent (90%) of the lowest volume weighted average price during the Pricing Period, subject to a floor of $0.50 per share.
- The timing and amounts of each Put shall be at the discretion of the Company.
- The maximum dollar amount of each Put will not exceed two times (2x) the average daily trading dollar volume for the Common Stock during the ten (10) consecutive Trading Days preceding the Put Notice Date.
- No Put will be made in an amount equaling less than ten thousand dollars ($10,000) or greater than five hundred thousand dollars ($500,000).
- GHS Investments will not be allowed to own more than 4.99% of Avant Technologies' outstanding stock at any given time.
- The agreement includes a registration rights agreement, requiring Avant Technologies to register the shares for resale.
- The company intends to use the proceeds from the sale of Put Shares for general corporate and working capital purposes and acquisitions or assets, businesses or operations or for other purposes that the Board of Directors, in good faith, deem to be in the best interest of the Company.
Sentiment
Score: 6
Explanation: The document outlines a financing agreement, which is generally neutral. However, the potential for dilution and market volatility introduces some negative sentiment. The company's limited operating history and need for additional capital also contribute to a slightly cautious outlook.
Positives
- The agreement provides Avant Technologies with access to a significant potential source of capital.
- The structure of the agreement allows Avant Technologies flexibility in determining the timing and amount of stock sales.
- The registration rights agreement enhances the liquidity of the shares for GHS Investments.
- The company intends to use the proceeds from the sale of Put Shares for general corporate and working capital purposes and acquisitions or assets, businesses or operations or for other purposes that the Board of Directors, in good faith, deem to be in the best interest of the Company.
Negatives
- The sale of common stock will dilute the ownership of existing Avant Technologies shareholders.
- The purchase price is tied to the market price of the stock, which could be volatile.
- The company may not be able to access the full $20 million available under the Equity Financing Agreement.
- The actual amount the Company can receive will depend on the trading price of its Common Stock at the time of each 'Put' transaction, as well as other market conditions and certain limitations set forth in the Agreement.
Risks
- The company's ability to access the full $20 million depends on market conditions and compliance with the agreement's terms.
- The market price of Avant Technologies' common stock may be volatile, affecting the proceeds from stock sales.
- The company's limited operating history and evolving industry make it difficult to evaluate future prospects.
- The company has not generated positive cash flow from operations, and its ability to do so is uncertain.
- The company may require additional capital to support business growth, which may not be available on acceptable terms.
- The company depends upon key personnel and needs additional personnel.
- The company's business requires substantial capital, and if it is unable to maintain adequate cash flows from operations, its profitability and financial condition will suffer.
- There is currently a limited public market for the company's common stock.
- If the company fails to maintain an effective system of internal controls, it may not be able to accurately report its financial results or prevent fraud.
- Because the company is quoted on the OTC QB marketplace instead of a national securities exchange, its investors may experience significant volatility in the market price of its stock and have difficulty selling their shares.
- The company's stock price and trading volume may be volatile, which could result in substantial losses for its stockholders.
- The company has not paid dividends in the past and has no immediate plans to pay cash dividends.
- Shares eligible for future sale may adversely affect the market for the company's Common Stock.
- You may experience future dilution as a result of future equity offerings.
- The company's charter documents and Nevada law may inhibit a takeover that stockholders consider favorable.
- There are limitations on director/officer liability.
- Penny stock regulations may impose certain restrictions on marketability of the company's securities.
- FINRA sales practice requirements may limit a stockholders ability to buy and sell the company's stock.
- The issuance of shares under the EPA is determined by a formula or pricing mechanism, which typically results in the issuance of a substantial number of shares at a discount to the market price.
- This could lead to dilution of our existing shareholders' ownership interest.
- As the number of shares outstanding increases, the market price of our common stock could be negatively impacted.
- This dilution may reduce the value of our shareholders investments and could make it more difficult for them to sell shares at favorable prices.
- While the EPA allows us the potential to raise substantial capital over time, there are factors that could limit our ability to access the full amount available under the equity line.
- These limitations include fluctuations in the market price and trading volume of our common stock, as well as certain conditions under the EPA.
- If the price of our stock declines or we fail to meet specific requirements under the EPA, we may not be able to draw the full amount of capital we anticipate, which could hinder our ability to fund operations or execute our business strategy.
- Following the announcement of a put under the EPA, there is a risk that investors may engage in short-selling activities, which could negatively affect the market price of our common stock.
- Short-selling involves borrowing and selling shares with the intention of repurchasing them at a lower price.
- If significant short-selling occurs, particularly after the announcement of a put but before shares are actually issued to GHS, the market price could experience downward pressure, which could make it more difficult for us to raise additional capital under the equity line and harm investor sentiment.
- The issuance of shares under the EPA may lead to significant dilution for our existing shareholders.
- Additionally, the sale of shares by GHS in the open market could put downward pressure on the price of our common stock, especially if GHS sells a large number of shares in a short period.
- Such market pressure could impact the stocks price and liquidity.
- GHS may engage in short selling, hedging activities, or market-making activities in our common stock, both before and after receiving shares under the EPA.
- These activities could contribute to further downward pressure on the stock price.
- Short-selling and hedging may create volatility, which could harm the market price of our common stock and adversely affect our ability to raise additional capital.
- GHS may sell or distribute the shares of common stock it acquires under the EPA.
- The timing and volume of such sales could affect the market price and liquidity of our common stock, leading to increased volatility.
- These sales could also make it more difficult for us to raise additional capital in the future.
- The EPA is subject to Regulation M under the Securities Exchange Act of 1934, which places restrictions on certain activities during the offering.
- Specifically, Regulation M prohibits GHS and any other distribution participants from: Market-Making Activities: GHS is prohibited from engaging in market-making activities, including buying or selling our common stock in a manner that could influence the market price while the equity line is in effect.
- Purchasing Shares in the Open Market: GHS is also restricted from purchasing shares of our common stock in the open market during the period in which the equity line is in effect, to prevent market manipulation during the offering process.
- These restrictions may limit GHS's ability to buy, sell, or trade our securities during the term of the equity line financing, which could affect the timing and manner in which shares are distributed.
Future Outlook
The company intends to use the net proceeds from this offering primarily for working capital and to support its joint venture with Ainnova Tech Inc. The company may reallocate proceeds among these categories as business needs and opportunities evolve.
Industry Context
Equity financing agreements are common in the micro-cap and small-cap sectors, providing companies with flexible access to capital. However, they also carry risks of dilution and market volatility.
Comparison to Industry Standards
- Comparable companies that have utilized similar equity financing agreements include those in the biotechnology, technology, and resource sectors.
- The terms of this agreement, such as the discount to market price and ownership limitations, are generally consistent with industry standards for similar financing arrangements.
- The specific terms, including the purchase price and put amounts, will likely be compared to similar deals involving companies with comparable market capitalizations and trading volumes.
Stakeholder Impact
- Shareholders will experience potential dilution of their ownership.
- Employees may benefit from the increased financial stability of the company.
- Customers may see improved products and services as a result of the funding.
- Suppliers and creditors may benefit from the company's improved financial position.
Next Steps
- Avant Technologies needs to file and have declared effective a Registration Statement with the SEC.
- The company will then have the option to issue Put Notices to GHS Investments to purchase shares of common stock.
- The company will need to manage the potential dilution and market impact of these stock sales.
Key Dates
| Date | Description |
|---|---|
| June 28, 2019 | The Company acquired Thy News LLC. |
| March 30, 2020 | The Company acquired Itnia Co. LLC. |
| March 6, 2023 | The Company filed a Certificate of Amendment to its Articles of Incorporation to increase the number of authorized shares of common stock. |
| April 3, 2023 | The Company entered into an Asset Purchase Agreement with GBT Tokenize Corp. to acquire Avant! AI assets. |
| April 3, 2023 | The Company entered into an Asset Purchase Agreement with Treasure Drive Ltd. to acquire Instant Fame assets. |
| April 5, 2024 | The Company entered into an Asset Purchase Agreement with Wired4Health, Inc. |
| May 7, 2024 | The Company filed a Certificate of Designation to its Articles of Incorporation designating 1,000,000 shares of its preferred stock. |
| July 17, 2024 | Effective date of the equity financing agreement and registration rights agreement with GHS Investments, LLC. |
| September 9, 2024 | Avant Technologies Inc. entered into a Cancellation Agreement with Wired4Health, Inc. |
| April 8, 2025 | The most recent trading price of Avant Technologies' common stock was $0.5. |
| April 11, 2025 | Date of the Prospectus. |
Keywords
Equity Financing, GHS Investments, Common Stock, Registration Rights, Capital Raise, Avant Technologies, Securities, Investment, Shares, SEC
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.